MyFinsight
Home
Blog
About
Contact
Download
Download image
Cash and cash
equivalents
$70,041,254
Prepaid expenses and
other current assets
$1,742,202
Total current assets
$71,783,456
Right-of-use assets
$275,861
Total assets
$72,059,317
Total liabilities and
stockholders equity
$72,059,317
Total stockholders
equity
$44,250,390
Total liabilities
$27,808,927
Accumulated deficit
-$483,957,253
Additional paid-in capital
$528,147,480
Total current
liabilities
$27,808,927
Common stock, voting,
0.001 par value...
$60,163
Current portion of debt
$15,249,632
Accrued expenses
$6,120,297
Deferred collaboration
revenue
$6,000,000
Operating lease
liabilities
$280,537
Accounts payable
$158,461
Back
Back
Balance Sheet
source: myfinsight.com
Aldeyra Therapeutics, Inc. (ALDX)
Aldeyra Therapeutics, Inc. (ALDX)